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Titin, also known as connectin, is a large ﬁlamentous protein that greatly contributes to passive myocardial stiﬀness. In vitro
evidence suggests that one of titin’s spring elements, the PEVK, interacts with actin and that this adds a viscous component to
passive stiﬀness. Diﬀerential splicing of titin gives rise to the stiﬀ N2B and more compliant N2BA isoforms. Here we studied the
titin-isoform dependence of titin-actin interaction and studied the bovine left atrium (BLA) that expresses mainly N2BA titin, and
the bovine left ventricle (BLV) that expresses a mixture of both N2B and N2BA isforms. For comparison we also studied mouse left
ventricular (MLV) myocardium which expresses predominately N2B titin. Using the actin-severing protein gelsolin, we obtained
evidence that titin-actin interaction contributes signiﬁcantly to passive myocardial stiﬀness in all tissue types, but most in MLV,
least in BLA, and an intermediate level in BLV. We also studied whether titin-actin interaction is regulated by S100A1/calcium and
found that calcium alone or S100A1 alone did not alter passive stiﬀness, but that combined they signiﬁcantly lowered stiﬀness. We
propose that titin-actin interaction is a “viscous break” that is on during diastole and oﬀ during systole.
1.Introduction
Passive tension development in the sarcomere plays a critical
role in diastolic function. The giant protein titin/connectin
spans the half-sarcomere from Z-disk to M-line [1] and is
responsibleforthedevelopmentofpassivetensionwithinthe
sarcomere [2]. Titin-based passive tension constitutes a large
fraction of the myocardial passive tension; the other main
contributor is the extracellular matrix [2, 3]. Titin contains
an extensible I-band region that comprises three distinct
regions: serially-linked immunoglobulin (Ig)-like domains,
the N2B element, and the PEVK region (which primarily
contains proline (P), glutamate (E), valine (V), and lysine
(K) residues) [4]. These three spring-like elements develop
force when extended and, along with collagen, determine
myocardial passive stiﬀness [5].
Isoform splicing is a long-term mechanism that alters
titin-based myocardial passive stiﬀness [6–8]. Cardiac titin is
present as two isoforms: the small (3.0MDa) N2B titin and
larger N2BA titin isoform (∼3.3MDa) [4, 6]. Diﬀerential
expression of titin’s I-band region results in N2BA titin
containing a larger PEVK domain than in N2B titin, in
addition to a variable number of additional Ig domains [4, 6,
9]. At a given extension, the cardiac N2BA isoform develops
less force than the N2B isoform, which can be explained by
its longer end-to-end length. This longer length results in
a lower fractional extension of the elastic elements in the
I-band, which leads to lower force development [10, 11].
Consistent with this, mouse knockout models, in which the
spring region of titin has been shortened, develop higher
passive force [12, 13].
Adding to the complexity of the sarcomeric response to
external stretch is the viscous interaction between cardiac
PEVK and actin [14–17]. In vitro motility assays [14–
16, 18], single molecule studies [19], myocyte mechanics
[14], electron microscopy [20], and single myoﬁbril recoil2 Journal of Biomedicine and Biotechnology
experiments [21] have provided evidence for a dynamic
interaction between the PEVK and F-actin that retards
ﬁlament sliding. As the sarcomeres change length during
active contraction (systole) and passive stretch (diastole),
titin’s I-band region and actin are displaced with respect to
one another. F-actin contains negatively-charged regions on
its outer surface [22], and the ionic strength dependence
of the PEVK-actin interaction suggests that electrostatic
interactions play a role in determining the magnitude of the
“viscousdrag”forceofthisinteraction[14].Invitroevidence
suggests that the PEVK-actin interaction might be regulated
by S100A1 [14], a soluble calcium-binding protein present
in the myocardium [23], with the interaction reduced in the
presence of S100A1 and physiological calcium levels. Thus,
isoformsplicingrepresentsalong-termresponsetochanging
demands on the cardiovascular system, and Ca2+/S100A1
modulated PEVK-actin association might represent a short-
term mechanism for changing passive stiﬀness.
The presence of titin-actin interaction has mainly been
investigated in N2B expressing rodent myocardium [14,
15]. However, large mammals, including human, typically
express higher levels of N2BA cardiac titin [8]a n dh e r e
we investigated titin-actin interaction in bovine left atrium
(BLA) which expresses predominately N2BA titin, and
bovine left ventricle (BLV) which coexpresses both N2B and
N2BA titin [24, 25]. We compared results to those from
the N2B dominant mouse left ventricle (MLV). We used
skinned myocardium and studied passive stiﬀness before
and after actin extraction using the actin severing protein
gelsolin. We also focused on the possible regulation of actin-
titin interaction by S100A1 and calcium, a mechanism of
regulation for which support exists from in vitro binding
and in vitro motility studies [14], but which has not been
tested in a sarcomeric context. The sarcomere has many
geometric constraints and contains countless proteins that
are absent in the in vitro assays, and these might mask or
accentuate properties measured in vitro. The ﬁndings of
our studies support that titin-actin interaction is universally
present in the diﬀerent titin isoforms, and that the level
scales with the stiﬀness of the isoform. We also found
support for regulation of titin-actin interaction by S100A1
and calcium in skinned myocardium. The data indicate that
during the cardiac cycle, titin-actin interaction ﬂuctuates,
and is strong during diastole when the calcium level is low
butconsiderablyweakerduringsystolewhencalciumishigh.
2.MaterialsandMethod
2.1. Muscles. Hearts were rapidly excised from ∼3mo old
C57/BL6, male mice. The left ventricle (LV) was opened
and immediately placed in a modiﬁed Krebs solution
[composition in mM: NaCl 122, KCl 5, NaHCO3 25,
MgCl2 1.08, NaH2PO4 1.3, CaCl2 0.2, 2, 3–6 butanedione
monoxime (BDM) 30, glucose 11.2, insulin 5U/L, gassed
with 95% O2,5 %C O 2, pH 7.4]. Bovine hearts (animals
>18 months old and weighing >1100lbs) were obtained
from local slaughterhouses. The hearts were excised within
∼15 minutes following death. The left atrium (LA) and
left ventricle were cut into small pieces and placed into
oxygenated Krebs solution. Small wall muscle strips (length:
1.5–3.0mm;diameter ∼0.3mm)weredissectedusingahigh-
resolution binocular scope. Extreme care was taken to dissect
the strips in the direction of the ﬁbers and to avoid stretching
during dissection. Visual inspection under the dissection
microscope revealed that some areas of the BLA contained
relatively high levels of collagen and these areas were avoided
in this study. Muscle strips were skinned in relaxing solution
(BES 40mM, EGTA 10mM, MgCl2 6.56mM, ATP 5.88mM,
DTT 1mM, K-propionate 46.35mM, creatine phosphate
15mM, pH 7.0) (chemicals from Sigma-Aldrich, MO, USA)
with 1% Triton-X-100, overnight at ∼4◦C. The muscle strips
were then washed and used for mechanical experiments.
To prevent degradation, all solutions contained protease
inhibitors (PMSF: 0.5mM; leupeptin: 0.04mM, and E64:
0.01mM). All animal experiments were approved by the
University of Arizona Institutional Animal Care and Use
Committee and followed the U.S. National Institutes of
Health “Using Animals in Intramural Research” guidelines
for animal use.
Passive tension was measured with a silicon semicon-
ductor strain gauge (model AE–801, SensoNor, Horten,
Norway). Muscle length was controlled by a high-speed
motor (Model 308B, Aurora Scientiﬁc Inc., Richmond Hill,
Ontario, Canada). Preparations were attached to the motor
arm and the force transducer via aluminum clips. Using a
small prism, the two perpendicular diameters of the muscle
were measured and the cross-sectional area was calculated,
assuming the cross-section is elliptical in shape. This area
was used to calculate the force per unit area (in mN/mm2),
allowing us to compare results from diﬀerent muscles.
Experiments were performed at room temperature (20–
22◦C). We determined titin’s contribution to total passive
tension using its fractional contribution in MLV, BLV, and
BLA as previously determined (this previous work used the
exact same experimental conditions as the present work); see
[3]. We also determined the passive stiﬀness from the local
slope of the titin-based tension-SL relation.
Sarcomere length (SL) was measured with laser-
diﬀraction [26, 27]. The diﬀraction pattern was collected
with a bright-ﬁeld objective, a telescope lens was focused
on the back focal plane of the objective, and the diﬀraction
pattern was projected, after compression with a cylindrical
lens,ontoaphotodiodearray.Theﬁrstorderdiﬀractionpeak
position was obtained using a digital spot-position detector
board installed in an IBM AT computer. This signal was
converted to sarcomere length using a calibration curve that
was established with diﬀraction peaks of a 25μm grating that
was present in the chamber. For further details see [26, 27].
Maximum active force was measured at an SL of
2.0μm, using an activating solution with pCa 4.5 (pCa =
−log [Ca2+]). Passive force was measured while the muscle
was in relaxing solution and stretching the preparation with
a constant velocity from its slack length to a predetermined
amplitude followed by a release to the slack length at
the same velocity. Most experiments were done utilizing
a stretch/release velocity of 0.1 length/sec with the length
referenced to the slack sarcomere length (∼1.9μm), exceptJournal of Biomedicine and Biotechnology 3
for those in Figure 6 that were done at both 0.1 and 2.0
length/sec. Stretch–release cycles were followed by ∼20-min
rest periods at the slack length.
To eliminate titin-actin interaction in the I-band region
of the sarcomere, we used a calcium-independent gelsolin
fragment (amino acids 1–406; dissolved in 10mM 3-(N-
morpholino) propanesulfonic acid (MOPS), 1.0mM EGTA,
1.0mM Mg-acetate, 20mM K-propionate, 1mM DTT, and
20μg/mL leupeptin, pH 7.0 at 21–23
◦C), as described
previously [28]. Skinned muscle strips were mechanically
characterized and the chamber solution was then replaced
by gelsolin (3μg/μL) in relaxing solution, as described
previously [29,30], and incubated atroom temperature for4
hours, followed by extensive washing with relaxing solution
and a mechanical characterization identical to the one
carried out before actin extraction. To determine the degree
of thin ﬁlament extraction, the maximal active tension (pCa
4.0) at a starting SL of 2.0μm was measured before and after
actin extraction.
To test the eﬀect of low level of calcium or S100A1,
a separate group of skinned muscles were incubated in a
relaxing solution (pCa 9.0), a calcium (pCa 6.8) solution
(solution composition calculated by the program of Fabiato
andFabiato[31]),andeitherarelaxingsolutionthatcontains
S100A1(1μg/μL; S100A1 from Sigma) or a solution that
contains both calcium (pCa 6.8) and S100A1. The skinned
muscles were incubated in these solutions and were then
stretch/released at 0.1 length/sec, allowed to rest 20 minutes,
and then stretch/released at 2.0 length/sec.
2.2. Statistics. Data are presented as mean ± SE. Signiﬁcant
diﬀerencesweredeterminedusingat-testorwhereappropri-
a t eA N O V A .P o s th o cc o m p a r i s o n sw e r em a d eu s i n gT u k e y
HSD. Probability values <. 05 were taken as signiﬁcant.
3. Results
We focused on the contribution of titin-actin interaction
to passive stiﬀness and its modulation via S100A1 and
calcium. We utilized myocardial wall strips from MLV, as a
representativeofamyocardiumthatexpressespredominately
N2B titin, BLA, as a representative of an N2BA dominant
sample, and BLV, as a representative of myocardium that
coexpresses both N2BA and N2B titin isoforms [11]. The
N2B:N2BA expression ratio in the BLV tissues was deter-
mined with agarose gels [32]t ob e1 . 2± 0.2; the inset of
Figure 1(b) shows an example of a gel with BLV and BLA
samples. We measured passive tension during stretch of the
skinned myocardium, before and after extracting actin with
gelsolin, in order to deduce whether actin-titin interaction
contributes to passive tension. To determine the degree of
actin extraction, we measured maximal active tension before
and after gelsolin treatment.
Gelsolin treatment resulted in a nearly 95% loss in active
tension (Table 1), suggesting that the majority of the thin
ﬁlamentswasextractedinalltissues,consistentwithprevious
work [28]. Although the remaining few percent of active
tension could have been eliminated by extending the gelsolin
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Figure 1: Measurements of total passive tension, before and after
gelsolin treatment. (a) mouse left ventricle (MLV), (b) bovine
left ventricle (BLV), (c) bovine left atrium (BLA) before gelsolin
extraction (control, black) and after gelsolin treatment (white).
Gelsolin treatment decreases passive tension. Inset of (b): example
of titin gel (SDS agarose) with BLV and BLA samples. Inset of (c):
tension at SL = 2.25μm before and after gelsolin treatment with %
tension reduction. MLV is more greatly aﬀected by thin ﬁlament
extraction than BLA, with BLV at an intermediate level. Error bars
are SE (for clarity plotted only every 0.05μm).
treatment duration, because this might recruit titin from
near the Z-disc [30], which is normally inextensible, we
limited the gelsolin treatment duration such that a very4 Journal of Biomedicine and Biotechnology
Table 1: Measurement of maximal active tension (pCa 4.5) before and after gelsolin treatment. Percent reduction not diﬀerent between
groups. (SL 2.0μm; n = 6 per group; data are mean ± SE;
∗∗∗P <. 001.
Muscle Dominant Isoform
Active tension before
gelsonlin treatment
(mN/mm2)
Active tension after
gelsonlin treatment
(mN/mm2)
Percent tension
reduction (%)
MLV N2B 36.7 ±0.92 . 2 5 ± 0.26∗∗∗ 93.8 ±0.8
BLV Coexpressing 41.8 ±1.52 . 2 4 ± 0.16∗∗∗ 94.6 ±0.3
BLA N2BA 33.2 ±0.52 . 3 1 ± 0.24∗∗∗ 93.0 ±0.7
smallamountofactivetensionremained.Thusbycomparing
passive stiﬀness of diﬀerent tissue types and utilizing gelsolin
as a tool to extract actin, we investigated the contribution of
titin-actin interaction to passive tension in N2B expressing
myocardium (MLV), N2BA expressing myocardium (BLA),
and N2B and N2BA coexpressing myocardium (BLV).
3 . 1 .C h a n g e si nP a s s i v eT e n s i o nb yT h i nF i l a m e n tE x t r a c t i o n .
Becausetitin-actininteractionisthoughttoprovideaviscous
force,thepassivetensionmeasuredduringstretchisexpected
to be increased by this interaction. We examined passive
tension during stretch to sarcomere length 2.25μmf o rM L V
or 2.4μm for BLV and BLA. MLV tissues were only stretched
to sarcomere lengths (SL) of 2.25μm so that the tissues
would not encounter damage [3]. BLA and BLV tissues
were stretched to SL of 2.4μm, which for these tissues is in
the reversible length regime [3]. Between tissue types, N2B
expressing MLV was found to be stiﬀer than N2B/N2BA
coexpressing BLV, which was stiﬀer than N2BA expressing
BLA (Figure 1, control curves), reproducing earlier ﬁndings
[3]. Following thin ﬁlament extraction, passive tension was
reduced and the magnitude was small at short lengths
and grew as SL increased (Figure 1). The eﬀect was most
pronounced in MLV, intermediate in BLV, and lowest in
BLA. Comparing data at an SL of 2.25μm, showed that the
magnitudeofthereductionwas22,17,and10%,respectively
(Figure 1(c), inset).
Results in Figure 1 represent total passive tension.
Previously, we determined titin’s and collagen’s fractional
contribution to total passive tension of MLV, BLV, and BLA
(using the exact same experimental conditions as in the
present work) and we used those results [3] to calculate from
the total measured tension (Figure 1), the titin-based passive
tension. Results are shown in Figure 2, with ﬁndings at an
SL of 2.25μm shown in the inset of Figure 2(c). The percent
titin-based passive tension reduction at the full SL range is
shown in Figure 3(a). In all tissue types, titin-based passive
tension increases with SL, and at all SLs the reduction is
largest in MLV, less in BLV, and lowest in BLA with values at
2.25μm of 44, 20, and 12%, respectively. We also determined
the passive stiﬀness from the local slope of the tension-SL
relation and calculated the stiﬀness reduction due to actin
extraction. Results shown in Figure 3(b) reveal that in all
three tissue types, actin extraction has a large eﬀect on titin-
based stiﬀness, and that the reduction is again largest in N2B
expressing MLV and smallest in N2BA expressing BLA with
BLV being intermediate.
3.2. Hysteresis in Thin Filament Extracted Tissue. It is well
known that passive tension displays hysteresis (i.e., passive
tension is higher during stretch than during release) and
because titin-actin interaction appears to contribute to
passive tension during stretch we wished to examine whether
titin-actin interaction contributes to hysteresis. In the three
muscle types, we imposed stretch-releases cycles before and
afterthinﬁlamentextractionanddeterminedhysteresisfrom
the area of the force-length loop of stretches to diﬀerent SLs
(an example of the protocol is shown in Figure 4(a)). In all
tissue types, hysteresis increased with SL and, interestingly,
gelsolin treatment signiﬁcantly decreased hysteresis at all
lengths. At an SL of 2.25μm( Figure 4(b)), the decrease
was the same in MLV and BLA (33 and 35%, resp.) and
larger in BLV (52%). It is important to highlight that
hysteresis is not abolished by actin extraction, showing
that titin-actin interaction is only partially responsible for
hysteresis and that there must be other sources of hysteresis
as well.
3.3. Modulation of Titin-Actin Interaction via S100A1 and
Ca2+. While titin-actin interactions might be useful in pro-
viding resistance to stretch during diastole, during systole,
these interactions could hinder ejection when thin ﬁlaments
rapidly slide past the extensible region of titin. Thus it is
worthexaminingwhethertitin-actin interactionisregulated.
Based on in vitro studies, we had previously proposed
that the Ca2+-binding protein S100A1 regulates actin-titin
interaction [3]. Here we investigated the possibility of
modulation of passive stiﬀness via S100A1 and Ca2+.W e
used a pCa of 6.8 because this is just below the level that
causes activation [33]. We focused on MLV because titin-
actin interactions are most pronounced in this tissue type,
making it easier to detect regulation, if indeed it exists.
The example experiment of Figure 5 shows that Ca2+ alone
or S100A1 alone did not change tension during stretch
(Figure 5(a))butthatwhencombined(pCa6.8plusS100A1)
passive tension was reduced (Figure 5(b)). We performed
experiments at two stretch speeds (0.1 and 2.0length/sec)
and their summarized results are shown in Figure 6. In the
presence of Ca2+ alone or S100A1 alone, passive tension
at both speeds was slightly increased compared to that
measured in Ca2+free solution (Figure 6, upper curves).
In the presence of both S100A1 and Ca2+, a signiﬁcant
decrease in passive stiﬀness was observed, with up to
20% decrease at the fastest speed (Figure 6,b o t t o mt w o
curves).Journal of Biomedicine and Biotechnology 5
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Figure 2: Measurements of titin-based passive tension, before and
after gelsolin treatment. (a)–(c) In MLV, BLV, and BLA titin-based
passive tension is reduced following gelsolin treatment. At a SL of
2.25μm. Decrease in titin-based passive tension is largest in MLV,
smallest in BLA, with BLV being intermediate. Data are based on
Figure 1; see text for details. Error bars are SE (for clarity plotted
only every 0.05μm).
4. Discussion
We found in this work that thin ﬁlament extraction, with
the actin-severing protein gelsolin, reduces passive tension
during stretch of skinned myocardium. These ﬁndings
support previous studies that suggest that passive tension
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Figure 3: Reduction in titin-based tension (a) and titin-based
stiﬀness (b). Data are based on measurements shown in Figure 2
(tension) and from the slope of the tension-SL curve shown in
Figure 2 (stiﬀness). The reductions in tension and stiﬀness are SL
dependent,inalltissuetypes,andarehighestinMLV,lowestinBLA
and intermediate in BLV. Error bars are SE (for clarity plotted only
every 0.05μm).
measured during stretch in cardiac muscle is not solely
determined by titin’s intrinsic elasticity, but also includes
contributions from a transient (or viscous) force that is
due to titin–actin interaction [14, 15]. In vitro binding and
motility studies have shown that amongst the three spring
elements of cardiac titin, the tandem Ig segments and N2B
element do not bind actin, but that the PEVK region does
interact with titin [14, 15, 18]. Important evidence for func-
tional signiﬁcance of titin-actin interaction was obtained
in mechanical experiments with mouse cardiac myocytes
in which a recombinant protein fragment consisting of the
PEVK region of the N2B titin isoform was added to skinned
myocytes, and passive tension during stretch was lowered
due to a competition with endogenous titin molecules
for binding sites on the thin ﬁlament [14]. Our present
work on mouse skinned myocardium in which we found
that thin ﬁlament extraction also lowers passive tension
during stretch, similarly to what had been found earlier in
myocytes with exogenous PEVK, further supports the notion
that titin-actin interaction contributes to passive tension6 Journal of Biomedicine and Biotechnology
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Figure 4: Hysteresis before and after gelsolin treatment. (a)
Protocol. Skinned muscles were stretched to a given length followed
by a release back to slack and hysteresis was calculated from the
area of the resultant force-sarcomere length curve. Measurements
were made before and after gelsolin treatment. (b) Comparison of
hysteresis at SL 2.25μm with % hysteresis reduction. All tissues
showed an increase in hysteresis with SL and a reduction in
hysteresisfollowingactinextractionwithgelsolin.ErrorbarsareSE.
∗P <. 01.
during stretch. Furthermore, our ﬁnding that thin ﬁlament
extraction lowers passive tension in bovine myocardium as
wellasmousemyocardium(Figures1–3)suggeststhatN2BA
cardiac titin also interacts with actin and that PEVK-titin
interaction is universally represented in diﬀerent cardiac
isoforms.
In vitro binding studies have shown that the binding
between F-actin and the PEVK is ionic strength dependent
[14, 18, 19], suggesting that the interaction is at least in
part electrostatic. F-actin contains a large patch of negatively
charged residues on its exposed surface [22], and several
actin-binding proteins are known to bind to this region
via basic charge clusters [34–36]. The PEVK region of N2B
cardiac titin is comprised of basic (pI 9-10) ∼28-residue
PEVK repeats [6, 37]. At physiological pH, the cardiac
PEVK therefore carries a net positive charge, which likely
facilitates its interaction with the negatively charged actin
ﬁlament. Proline-rich regions (PRRs) often assume extended
conformations, such as the polyproline II (PPII)-helix that
has been predicted for PEVK fragments [38]. Due to the
conformational restrictions that proline residues impose on
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Figure 5: Example experiment addressing eﬀect of calcium and
S100A1 on tension in skinned muscle during stretch. (a) Skinned
MLV muscle was stretched (0.1 length/sec) in pCa 9.0 (black),
pCa 6.8 (red), and pCa 9.0 plus S100A1 solution (blue). Calcium
(pCa 6.8) or S100A1 alone did not aﬀect tension during stretch.
(b) Skinned MLV muscle was stretched (0.1 length/sec) in pCa 9.0
(black), pCa 6.8 (red squares), and pCa 6.8 plus S100A1 solution
(red triangles). Only when calcium (pCa 6.8) and S100A1 are both
present is passive tension reduced.
the polypeptide backbone, PRRs experience a small reduc-
tion of entropy upon ligand binding [39]. This property
makes them energetically favorable sites for protein-protein
interactions, and there are numerous examples of PRRs that
perform binding functions in vivo [39]. The binding of actin
by the N2B PEVK may therefore be both electrostatically and
thermodynamically favorable.
The in vitro studies discussed above were all carried
out with a recombinant PEVK fragment that represents the
PEVK sequence found in the human N2B cardiac isoform.
The high sequence conservation of the N2B PEVK [28]
makes it likely that the same binding properties exist in
diﬀerent species. Additionally, the PEVK sequence of the
N2B titin isoform is constitutively expressed in diﬀerent
titin isoforms and thus PEVK-titin interaction is expected
to occur in N2BA cardiac titin as well [4, 7, 28]. The
N2BA isoform contains additional PEVK residues many of
which belong to the above discussed PEVK repeat sequence
motif. Others belong to a second PEVK motif (absent in the
N2B isoform), the so-called E-rich motif which contains a
preponderance of glutamate [4, 40]. Nagy et al. [18] studiedJournal of Biomedicine and Biotechnology 7
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Figure 6: Eﬀect of calcium, S100A1, and calcium plus S100A1 on
tension. Skinned MLV was stretched at two velocities (0.1 and 2.0
length/sec;darkandopensymbols,resp.)incalciumalone(pCa6.8;
grey), S100A1 alone (circles), or calcium plus S100A1 (triangles).
Calcium alone or S100A1 alone slightly increases tension (3–8%).
When S100A1 is added to pCa 6.8 solutions, tension is decreased,
an eﬀect that is largest at the fastest stretch speed. Tensions are
expressed relative to tensions measure in the pCa 9.0 solution (See
methodsfordetails).ErrorbarsareSE(forclarityplottedonlyevery
0.05μm).
recombinant PEVK proteins with diﬀerent motif structures
and found that the presence of E-rich motifs enhances the
actin binding property of the PEVK. Thus, although the
PEVK of the N2BA isoform has not been studied in vitro,
it is expected that PEVK-actin interaction is present in this
titin isoform, consistent with our present ﬁndings.
We found that the eﬀect of thin ﬁlament extraction
was highest in N2B expressing MLV and lowest in N2BA
expressing BLA. Although this might suggest that the
interaction between the PEVK and actin is less in N2BA
titin, as discussed above, this is unlikely to be the case (the
interaction might actually be enhanced in N2BA titin) and it
is worthwhile therefore to explore alternative explanations. A
likely explanation is as follows. The interaction between the
PEVK region and the actin ﬁlament will during sarcomere
stretch impede the extension of the PEVK element, and as
a result the extension of the tandem Ig and N2B spring
elements(whichdonotinteractwithactin)willbeincreased.
The degree to which this increased extension aﬀects force
will depend on how much it will increase titin’s fractional
extension (end-to-end length divided by the contour length)
[41–43]. Because N2BA titin has a much longer contour
length than N2B titin (due to the extra PEVK residues and
additional Ig domains), its increase in fractional extension
will be less and hence its increase in force will be less as
well (titin’s force is a function of its fractional extension; see
[41, 44]). Thus, our ﬁndings are consistent with a model
in which all titin isoforms interact with actin and in which
the isoform’s contour length in inversely related to the titin-
actin interaction induced force increase. The contour length
ofN2BAtitinislongerthanthatofN2Btitin[11],explaining
why the passive tension increase of BLA is much lower than
that of MLV. It is also important to highlight that although
the eﬀect of titin-thin ﬁlament interaction at a given SL is
lower in bovine tissues than in mouse, the eﬀects are more
similar in the two species when they are compared at their
end diastolic SL, which in large mammals has been reported
to be ∼2.4μm[45],andinrodents ∼2.2μm[46].Thus,titin-
actin interaction is likely to play important physiological
roles in species as diverse as mouse and bovine.
We have previously shown a correlation between the
level of N2B expression and heart beat frequency [8]. We
proposed that the short times available for diastolic ﬁlling
when the heart beats fast (in the mouse, the ﬁlling time is
only ∼40msec) necessitates a stiﬀ ventricle, to ensure that
early diastolic ﬁlling is fast (titin contributes to the early
diastolic suction force [47–49]) and that during late diastole,
overﬁlling is prevented [8]. Because the increased stiﬀness
due to titin-actin interaction is most pronounced at longer
SLs (Figure 3(b)), titin-actin interaction might function
primarily as a determinant of the maximal ﬁlling volume.
It is also important to highlight that the contribution of
titin-actin interaction to passive stiﬀness increases with
stretch speed (due to its viscous nature, see e.g., [19]), and
thus as the heart beats more forceful and faster (as occurs
during beta-adrenergic stimulation) titin-actin interaction
will further increase stiﬀness at the large volumes and
enhance thereby control over the maximal ﬁlling volume.
Titinalsoplaysastructuralrolethatincludescenteringofthe
A-band in the middle of the sarcomere [50]. Any unevenness
in active force generation in the two halves of a sarcomere
(which might be due to, for example, micro-variation in the
timing of calcium release) is expected to result during systole
in movement of the A-band away from its central location in
the sarcomere. During diastole, passive tension will reset the
A-bandtoitscentrallocation.However,ifdiastolicdurations
are extremely short, this is hard to accomplish and stiﬀ
titin will speed recentering, with a viscous component at
longer length preventing overshoot and possible oscillations.
Thus, we propose that titin-actin interaction is important
for controlling both late diastolic ﬁlling and the structural
integrity of the sarcomere.
Although titin-actin interaction is likely to be func-
tionally important during diastole, during systole it is not
beneﬁcial because it impedes ﬁlament sidling. It has been
shown in vitro that S100A1 regulates PEVK-actin interaction
[14] and, thus, S100A1 might provide a mechanism for
switching PEVK-actin interaction oﬀ during part of the
heart cycle when it is not a desirable feature to have. S100
is a 25-member family of EF hand proteins, with S100A1
as the most abundant member found in the heart [23].
Physiological levels of calcium activate S100A1, by exposing
a hydrophobic domain on S100A1 that is a primary site
for protein interactions [23]. Immunoelectron microscopy
has shown that in the presence of calcium, S100A1 binds8 Journal of Biomedicine and Biotechnology
at several sites along titin’s extensible region, including the
PEVK domain [14]. Furthermore, gel overlay analysis has
revealed that S100A1 binds the PEVK region in a calcium-
dependent manner, and in vitro motility assays indicate that
S100A1-PEVK interaction reduces the force that arises as
F-actin slides relative to the PEVK domain [14]. Thus we
had previously proposed that S100A1 provides a mechanism
to free the thin ﬁlament from titin and reduce titin-based
tension before active contraction and rapid ﬁlament sliding
take place [14]. The present work is the ﬁrst critical test of
this proposal. We used a low level of calcium (pCa 6.8), just
below the threshold for contraction, and showed that this
alone has no clear eﬀect on tension of skinned myocardium
during stretch, and neither has S100A1 alone (5 and 6).
However, when both are present, a signiﬁcant reduction in
passive tension during stretch is observed, that scales with
stretch speed, as expected from being derived from a viscous
source. Thus because S100A1 is constant during the cardiac
cycle,andcalciumﬂuctuates,titin-actininteractionwillvary:
it is strong during diastole when the calcium level is low but
considerably weaker during systole when calcium is high.
In summary, our studies support that all cardiac titin
isoforms interact with actin and that the degree to which
this increases passive stiﬀness is inversely related to the
isoform’s contour length. Titin-actin interaction is expected
to contribute to the structural integrity of the sarcomere
(A-band centering) and the control of late diastolic ﬁlling.
Furthermore, evidence was obtained for regulation of titin-
actin interaction by S100A1/Ca2+. We propose that titin-
actin interaction functions as “viscous break” that is on
during diastole and oﬀ during systole.
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